Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 77 entries
Sorted by: Best Match Show Resources per page
Late gadolinium enhancement (LGE) progresses with right ventricle volume in children after repair of tetralogy of fallot.

International journal of cardiology. Heart & vessels

Ylitalo P, Pitkänen OM, Lauerma K, Holmström M, Rahkonen O, Heikinheimo M, Sairanen H, Jokinen E.
PMID: 29450164
Int J Cardiol Heart Vessel. 2014 Feb 12;3:15-20. doi: 10.1016/j.ijchv.2014.01.002. eCollection 2014 Jun.

BACKGROUND: Fibrosis after myocardial damage can be determined by cardiac magnetic resonance (CMR) with late gadolinium enhancement (LGE). We studied whether ventricular LGE is visible in the ventricles of pediatric and adolescent TOF (tetralogy of Fallot) patients by measuring...

Cite
Ylitalo P, Pitkänen OM, Lauerma K, et al. Late gadolinium enhancement (LGE) progresses with right ventricle volume in children after repair of tetralogy of fallot. Int J Cardiol Heart Vessel. 2014;3:15-20doi: 10.1016/j.ijchv.2014.01.002.
Ylitalo, P., Pitkänen, O. M., Lauerma, K., Holmström, M., Rahkonen, O., Heikinheimo, M., Sairanen, H., & Jokinen, E. (2014). Late gadolinium enhancement (LGE) progresses with right ventricle volume in children after repair of tetralogy of fallot. International journal of cardiology. Heart & vessels, 315-20. https://doi.org/10.1016/j.ijchv.2014.01.002
Ylitalo, Pekka, et al. "Late gadolinium enhancement (LGE) progresses with right ventricle volume in children after repair of tetralogy of fallot." International journal of cardiology. Heart & vessels vol. 3 (2014): 15-20. doi: https://doi.org/10.1016/j.ijchv.2014.01.002
Ylitalo P, Pitkänen OM, Lauerma K, Holmström M, Rahkonen O, Heikinheimo M, Sairanen H, Jokinen E. Late gadolinium enhancement (LGE) progresses with right ventricle volume in children after repair of tetralogy of fallot. Int J Cardiol Heart Vessel. 2014 Feb 12;3:15-20. doi: 10.1016/j.ijchv.2014.01.002. eCollection 2014 Jun. PMID: 29450164; PMCID: PMC5801263.
Copy Download .nbib Format: NLM
[Not Available].

Duodecim; laaketieteellinen aikakauskirja

Pelkonen O, Pasanen M.
PMID: 17233355
Duodecim. 2006;122(20):2491-6.

No abstract available.

Cite
Pelkonen O, Pasanen M. Kauan käytössa olleiden Lääkkeiden yllättävät haittavaikutukset. [Not Available]. Duodecim. 2006;122(20):2491-6
Pelkonen, O., & Pasanen, M. (2006). Kauan käytössa olleiden Lääkkeiden yllättävät haittavaikutukset. [Not Available]. Duodecim; laaketieteellinen aikakauskirja, 122(20), 2491-6.
Pelkonen, Olavi, and Pasanen, Markku. "Kauan käytössa olleiden Lääkkeiden yllättävät haittavaikutukset." [Not Available]. Duodecim; laaketieteellinen aikakauskirja vol. 122,20 (2006): 2491-6.
Pelkonen O, Pasanen M. Kauan käytössa olleiden Lääkkeiden yllättävät haittavaikutukset. [Not Available]. Duodecim. 2006;122(20):2491-6. Finnish. PMID: 17233355.
Copy Download .nbib Format: NLM
Label-free mass spectrometry proteome quantification of human embryonic kidney cells following 24 hours of sialic acid overproduction.

Proteome science

Parviainen VI, Joenväärä S, Tohmola N, Renkonen R.
PMID: 23915316
Proteome Sci. 2013 Aug 01;11(1):38. doi: 10.1186/1477-5956-11-38.

BACKGROUND: Cell surface glycoprotein sialylation is one of the most ubiquitous glycan modifications found on higher eukaryotes. The surface sialylation pattern of cells is influenced by the cellular environment but also by the Golgi sialyltransferase activity and flux of...

Cite
Parviainen VI, Joenväärä S, Tohmola N, et al. Label-free mass spectrometry proteome quantification of human embryonic kidney cells following 24 hours of sialic acid overproduction. Proteome Sci. 2013;11(1):38doi: 10.1186/1477-5956-11-38.
Parviainen, V. I., Joenväärä, S., Tohmola, N., & Renkonen, R. (2013). Label-free mass spectrometry proteome quantification of human embryonic kidney cells following 24 hours of sialic acid overproduction. Proteome science, 11(1), 38. https://doi.org/10.1186/1477-5956-11-38
Parviainen, Ville I, et al. "Label-free mass spectrometry proteome quantification of human embryonic kidney cells following 24 hours of sialic acid overproduction." Proteome science vol. 11,1 (2013): 38. doi: https://doi.org/10.1186/1477-5956-11-38
Parviainen VI, Joenväärä S, Tohmola N, Renkonen R. Label-free mass spectrometry proteome quantification of human embryonic kidney cells following 24 hours of sialic acid overproduction. Proteome Sci. 2013 Aug 01;11(1):38. doi: 10.1186/1477-5956-11-38. PMID: 23915316; PMCID: PMC3750590.
Copy Download .nbib Format: NLM
Technetium-99m in the study of rheumatic joints.

Scandinavian journal of rheumatology

Oka M, Rekonen A, Ruotsi A.
PMID: 20144118
Scand J Rheumatol. 1987;16(1):271-9. doi: 10.3109/03009747009165380.

The accumulation of Tc-99m in knee and finger joints was studied in 41 rheumatic patients and 25 controls. The accumulation of the radioisotope was correlated with the intensity of active inflammation. Rheumatoid joints showed a stronger Tc-99m uptake than...

Cite
Oka M, Rekonen A, Ruotsi A. Technetium-99m in the study of rheumatic joints. Scand J Rheumatol. 1987;16(1):271-9doi: 10.3109/03009747009165380.
Oka, M., Rekonen, A., & Ruotsi, A. (1987). Technetium-99m in the study of rheumatic joints. Scandinavian journal of rheumatology, 16(1), 271-9. https://doi.org/10.3109/03009747009165380
Oka, M, et al. "Technetium-99m in the study of rheumatic joints." Scandinavian journal of rheumatology vol. 16,1 (1987): 271-9. doi: https://doi.org/10.3109/03009747009165380
Oka M, Rekonen A, Ruotsi A. Technetium-99m in the study of rheumatic joints. Scand J Rheumatol. 1987;16(1):271-9. doi: 10.3109/03009747009165380. PMID: 20144118.
Copy Download .nbib Format: NLM
Gremlin-1 associates with fibrillin microfibrils in vivo and regulates mesothelioma cell survival through transcription factor slug.

Oncogenesis

Tamminen JA, Parviainen V, Rönty M, Wohl AP, Murray L, Joenväärä S, Varjosalo M, Leppäranta O, Ritvos O, Sengle G, Renkonen R, Myllärniemi M, Koli K.
PMID: 23978876
Oncogenesis. 2013 Aug 26;2:e66. doi: 10.1038/oncsis.2013.29.

Malignant mesothelioma is a form of cancer that is highly resistant to conventional cancer therapy for which no major therapeutic advances have been introduced. Here, we identify gremlin-1, a known bone morphogenetic protein inhibitor crucial for embryonic development, as...

Cite
Tamminen JA, Parviainen V, Rönty M, et al. Gremlin-1 associates with fibrillin microfibrils in vivo and regulates mesothelioma cell survival through transcription factor slug. Oncogenesis. 2013;2:e66doi: 10.1038/oncsis.2013.29.
Tamminen, J. A., Parviainen, V., Rönty, M., Wohl, A. P., Murray, L., Joenväärä, S., Varjosalo, M., Leppäranta, O., Ritvos, O., Sengle, G., Renkonen, R., Myllärniemi, M., & Koli, K. (2013). Gremlin-1 associates with fibrillin microfibrils in vivo and regulates mesothelioma cell survival through transcription factor slug. Oncogenesis, 2e66. https://doi.org/10.1038/oncsis.2013.29
Tamminen, J A, et al. "Gremlin-1 associates with fibrillin microfibrils in vivo and regulates mesothelioma cell survival through transcription factor slug." Oncogenesis vol. 2 (2013): e66. doi: https://doi.org/10.1038/oncsis.2013.29
Tamminen JA, Parviainen V, Rönty M, Wohl AP, Murray L, Joenväärä S, Varjosalo M, Leppäranta O, Ritvos O, Sengle G, Renkonen R, Myllärniemi M, Koli K. Gremlin-1 associates with fibrillin microfibrils in vivo and regulates mesothelioma cell survival through transcription factor slug. Oncogenesis. 2013 Aug 26;2:e66. doi: 10.1038/oncsis.2013.29. PMID: 23978876; PMCID: PMC3759128.
Copy Download .nbib Format: NLM
Application of the UHPLC-DIA-HRMS Method for Determination of Cheese Peptides.

Foods (Basel, Switzerland)

Arju G, Taivosalo A, Pismennoi D, Lints T, Vilu R, Daneberga Z, Vorslova S, Renkonen R, Joenvaara S.
PMID: 32718013
Foods. 2020 Jul 23;9(8). doi: 10.3390/foods9080979.

Until now, cheese peptidomics approaches have been criticised for their lower throughput. Namely, analytical gradients that are most commonly used for mass spectrometric detection are usually over 60 or even 120 min. We developed a cheese peptide mapping method...

Cite
Arju G, Taivosalo A, Pismennoi D, et al. Application of the UHPLC-DIA-HRMS Method for Determination of Cheese Peptides. Foods. 2020;9(8)doi: 10.3390/foods9080979.
Arju, G., Taivosalo, A., Pismennoi, D., Lints, T., Vilu, R., Daneberga, Z., Vorslova, S., Renkonen, R., & Joenvaara, S. (2020). Application of the UHPLC-DIA-HRMS Method for Determination of Cheese Peptides. Foods (Basel, Switzerland), 9(8), . https://doi.org/10.3390/foods9080979
Arju, Georg, et al. "Application of the UHPLC-DIA-HRMS Method for Determination of Cheese Peptides." Foods (Basel, Switzerland) vol. 9,8 (2020). doi: https://doi.org/10.3390/foods9080979
Arju G, Taivosalo A, Pismennoi D, Lints T, Vilu R, Daneberga Z, Vorslova S, Renkonen R, Joenvaara S. Application of the UHPLC-DIA-HRMS Method for Determination of Cheese Peptides. Foods. 2020 Jul 23;9(8). doi: 10.3390/foods9080979. PMID: 32718013; PMCID: PMC7466222.
Copy Download .nbib Format: NLM
Investigation into experimental toxicological properties of plant protection products having a potential link to Parkinson's disease and childhood leukaemia.

EFSA journal. European Food Safety Authority

, Ockleford C, Adriaanse P, Berny P, Brock T, Duquesne S, Grilli S, Hernandez-Jerez AF, Bennekou SH, Klein M, Kuhl T, Laskowski R, Machera K, Pelkonen O, Pieper S, Smith R, Stemmer M, Sundh I, Teodorovic I, Tiktak A, Topping CJ, Wolterink G, Angeli K, Fritsche E, Hernandez-Jerez AF, Leist M, Mantovani A, Menendez P, Pelkonen O, Price A, Viviani B, Chiusolo A, Ruffo F, Terron A, Bennekou SH.
PMID: 32625422
EFSA J. 2017 Mar 16;15(3):e04691. doi: 10.2903/j.efsa.2017.4691. eCollection 2017 Mar.

In 2013, EFSA published a literature review on epidemiological studies linking exposure to pesticides and human health outcome. As a follow up, the EFSA Panel on Plant Protection Products and their residues (PPR Panel) was requested to investigate the...

Cite
, Ockleford C, Adriaanse P, et al. Investigation into experimental toxicological properties of plant protection products having a potential link to Parkinson's disease and childhood leukaemia. EFSA J. 2017;15(3):e04691doi: 10.2903/j.efsa.2017.4691.
, Ockleford, C., Adriaanse, P., Berny, P., Brock, T., Duquesne, S., Grilli, S., Hernandez-Jerez, A. F., Bennekou, S. H., Klein, M., Kuhl, T., Laskowski, R., Machera, K., Pelkonen, O., Pieper, S., Smith, R., Stemmer, M., Sundh, I., Teodorovic, I., Tiktak, A., Topping, C. J., Wolterink, G., Angeli, K., Fritsche, E., Hernandez-Jerez, A. F., Leist, M., Mantovani, A., Menendez, P., Pelkonen, O., Price, A., Viviani, B., Chiusolo, A., Ruffo, F., Terron, A., & Bennekou, S. H. (2017). Investigation into experimental toxicological properties of plant protection products having a potential link to Parkinson's disease and childhood leukaemia. EFSA journal. European Food Safety Authority, 15(3), e04691. https://doi.org/10.2903/j.efsa.2017.4691
, et al. "Investigation into experimental toxicological properties of plant protection products having a potential link to Parkinson's disease and childhood leukaemia." EFSA journal. European Food Safety Authority vol. 15,3 (2017): e04691. doi: https://doi.org/10.2903/j.efsa.2017.4691
, Ockleford C, Adriaanse P, Berny P, Brock T, Duquesne S, Grilli S, Hernandez-Jerez AF, Bennekou SH, Klein M, Kuhl T, Laskowski R, Machera K, Pelkonen O, Pieper S, Smith R, Stemmer M, Sundh I, Teodorovic I, Tiktak A, Topping CJ, Wolterink G, Angeli K, Fritsche E, Hernandez-Jerez AF, Leist M, Mantovani A, Menendez P, Pelkonen O, Price A, Viviani B, Chiusolo A, Ruffo F, Terron A, Bennekou SH. Investigation into experimental toxicological properties of plant protection products having a potential link to Parkinson's disease and childhood leukaemia. EFSA J. 2017 Mar 16;15(3):e04691. doi: 10.2903/j.efsa.2017.4691. eCollection 2017 Mar. PMID: 32625422; PMCID: PMC7233269.
Copy Download .nbib Format: NLM
Toxicology Meets Pharmacodynamics and Pharmacokinetics - New Concepts, Models and In Vitro Approaches and Tools.

Basic & clinical pharmacology & toxicology

Heinonen T, Pelkonen O, Tähti H.
PMID: 29938893
Basic Clin Pharmacol Toxicol. 2018 Sep;123:3-5. doi: 10.1111/bcpt.13080. Epub 2018 Aug 22.

No abstract available.

Cite
Heinonen T, Pelkonen O, Tähti H. Toxicology Meets Pharmacodynamics and Pharmacokinetics - New Concepts, Models and In Vitro Approaches and Tools. Basic Clin Pharmacol Toxicol. 2018;123:3-5doi: 10.1111/bcpt.13080.
Heinonen, T., Pelkonen, O., & Tähti, H. (2018). Toxicology Meets Pharmacodynamics and Pharmacokinetics - New Concepts, Models and In Vitro Approaches and Tools. Basic & clinical pharmacology & toxicology, 1233-5. https://doi.org/10.1111/bcpt.13080
Heinonen, Tuula, et al. "Toxicology Meets Pharmacodynamics and Pharmacokinetics - New Concepts, Models and In Vitro Approaches and Tools." Basic & clinical pharmacology & toxicology vol. 123 (2018): 3-5. doi: https://doi.org/10.1111/bcpt.13080
Heinonen T, Pelkonen O, Tähti H. Toxicology Meets Pharmacodynamics and Pharmacokinetics - New Concepts, Models and In Vitro Approaches and Tools. Basic Clin Pharmacol Toxicol. 2018 Sep;123:3-5. doi: 10.1111/bcpt.13080. Epub 2018 Aug 22. PMID: 29938893.
Copy Download .nbib Format: NLM
Health inequalities in modern societies and beyond. Introduction.

Social science & medicine (1982)

Lahelma E, Rahkonen O.
PMID: 9080557
Soc Sci Med. 1997 Mar;44(6):721-2. doi: 10.1016/s0277-9536(97)88373-6.

No abstract available.

Cite
Lahelma E, Rahkonen O. Health inequalities in modern societies and beyond. Introduction. Soc Sci Med. 1997;44(6):721-2doi: 10.1016/s0277-9536(97)88373-6.
Lahelma, E., & Rahkonen, O. (1997). Health inequalities in modern societies and beyond. Introduction. Social science & medicine (1982), 44(6), 721-2. https://doi.org/10.1016/s0277-9536(97)88373-6
Lahelma, E, and Rahkonen, O. "Health inequalities in modern societies and beyond. Introduction." Social science & medicine (1982) vol. 44,6 (1997): 721-2. doi: https://doi.org/10.1016/s0277-9536(97)88373-6
Lahelma E, Rahkonen O. Health inequalities in modern societies and beyond. Introduction. Soc Sci Med. 1997 Mar;44(6):721-2. doi: 10.1016/s0277-9536(97)88373-6. PMID: 9080557.
Copy Download .nbib Format: NLM
Scientific Opinion of the Scientific Panel on Plant Protection Products and their Residues (PPR Panel) on testing and interpretation of comparative .

EFSA journal. European Food Safety Authority

, Hernandez-Jerez AF, Adriaanse P, Aldrich A, Berny P, Coja T, Duquesne S, Focks A, Marinovich M, Millet M, Pelkonen O, Pieper S, Tiktak A, Topping CJ, Widenfalk A, Wilks M, Wolterink G, Gundert-Remy U, Louisse J, Rudaz S, Testai E, Lostia A, Dorne JL, Parra Morte JM.
PMID: 34987623
EFSA J. 2021 Dec 23;19(12):e06970. doi: 10.2903/j.efsa.2021.6970. eCollection 2021 Dec.

EFSA asked the Panel on Plant Protection Products and their residues to deliver a Scientific Opinion on testing and interpretation of comparative

Cite
, Hernandez-Jerez AF, Adriaanse P, et al. Scientific Opinion of the Scientific Panel on Plant Protection Products and their Residues (PPR Panel) on testing and interpretation of comparative . EFSA J. 2021;19(12):e06970doi: 10.2903/j.efsa.2021.6970.
, Hernandez-Jerez, A. F., Adriaanse, P., Aldrich, A., Berny, P., Coja, T., Duquesne, S., Focks, A., Marinovich, M., Millet, M., Pelkonen, O., Pieper, S., Tiktak, A., Topping, C. J., Widenfalk, A., Wilks, M., Wolterink, G., Gundert-Remy, U., Louisse, J., Rudaz, S., Testai, E., Lostia, A., Dorne, J. L., & Parra Morte, J. M. (2021). Scientific Opinion of the Scientific Panel on Plant Protection Products and their Residues (PPR Panel) on testing and interpretation of comparative . EFSA journal. European Food Safety Authority, 19(12), e06970. https://doi.org/10.2903/j.efsa.2021.6970
, et al. "Scientific Opinion of the Scientific Panel on Plant Protection Products and their Residues (PPR Panel) on testing and interpretation of comparative ." EFSA journal. European Food Safety Authority vol. 19,12 (2021): e06970. doi: https://doi.org/10.2903/j.efsa.2021.6970
, Hernandez-Jerez AF, Adriaanse P, Aldrich A, Berny P, Coja T, Duquesne S, Focks A, Marinovich M, Millet M, Pelkonen O, Pieper S, Tiktak A, Topping CJ, Widenfalk A, Wilks M, Wolterink G, Gundert-Remy U, Louisse J, Rudaz S, Testai E, Lostia A, Dorne JL, Parra Morte JM. Scientific Opinion of the Scientific Panel on Plant Protection Products and their Residues (PPR Panel) on testing and interpretation of comparative . EFSA J. 2021 Dec 23;19(12):e06970. doi: 10.2903/j.efsa.2021.6970. eCollection 2021 Dec. PMID: 34987623; PMCID: PMC8696562.
Copy Download .nbib Format: NLM
Diseases with oral manifestations among adult asthmatics in Finland: a population-based matched cohort study.

BMJ open

Lemmetyinen R, Karjalainen J, But A, Renkonen R, Pekkanen J, Haukka J, Toppila-Salmi S.
PMID: 34972766
BMJ Open. 2021 Dec 31;11(12):e053133. doi: 10.1136/bmjopen-2021-053133.

OBJECTIVES: Many comorbidities are associated with adult asthma and may exacerbate the asthma burden of disease. This study aims to investigate the risk for major oral diseases or oral-manifesting diseases in asthmatic compared with non-asthmatic adults.DESIGN: We conducted a...

Cite
Lemmetyinen R, Karjalainen J, But A, et al. Diseases with oral manifestations among adult asthmatics in Finland: a population-based matched cohort study. BMJ Open. 2021;11(12):e053133doi: 10.1136/bmjopen-2021-053133.
Lemmetyinen, R., Karjalainen, J., But, A., Renkonen, R., Pekkanen, J., Haukka, J., & Toppila-Salmi, S. (2021). Diseases with oral manifestations among adult asthmatics in Finland: a population-based matched cohort study. BMJ open, 11(12), e053133. https://doi.org/10.1136/bmjopen-2021-053133
Lemmetyinen, Riikka, et al. "Diseases with oral manifestations among adult asthmatics in Finland: a population-based matched cohort study." BMJ open vol. 11,12 (2021): e053133. doi: https://doi.org/10.1136/bmjopen-2021-053133
Lemmetyinen R, Karjalainen J, But A, Renkonen R, Pekkanen J, Haukka J, Toppila-Salmi S. Diseases with oral manifestations among adult asthmatics in Finland: a population-based matched cohort study. BMJ Open. 2021 Dec 31;11(12):e053133. doi: 10.1136/bmjopen-2021-053133. PMID: 34972766.
Copy Download .nbib Format: NLM
Life-course socioeconomic circumstances in acute, chronic and disabling pain among young employees: a double suffering.

Scandinavian journal of public health

Fagerlund P, Salmela J, Pietiläinen O, Salonsalmi A, Rahkonen O, Lallukka T.
PMID: 34965800
Scand J Public Health. 2021 Dec 29;14034948211062314. doi: 10.1177/14034948211062314. Epub 2021 Dec 29.

BACKGROUND: Pain is known to be socioeconomically patterned and associated with disability. However, knowledge is scarce concerning life-course socioeconomic circumstances and pain among young adults. Our aim was to examine the associations of childhood and current socioeconomic circumstances with...

Cite
Fagerlund P, Salmela J, Pietiläinen O, et al. Life-course socioeconomic circumstances in acute, chronic and disabling pain among young employees: a double suffering. Scand J Public Health. 2021;14034948211062314doi: 10.1177/14034948211062314.
Fagerlund, P., Salmela, J., Pietiläinen, O., Salonsalmi, A., Rahkonen, O., & Lallukka, T. (2021). Life-course socioeconomic circumstances in acute, chronic and disabling pain among young employees: a double suffering. Scandinavian journal of public health, 14034948211062314. https://doi.org/10.1177/14034948211062314
Fagerlund, Pi, et al. "Life-course socioeconomic circumstances in acute, chronic and disabling pain among young employees: a double suffering." Scandinavian journal of public health vol. (2021): 14034948211062314. doi: https://doi.org/10.1177/14034948211062314
Fagerlund P, Salmela J, Pietiläinen O, Salonsalmi A, Rahkonen O, Lallukka T. Life-course socioeconomic circumstances in acute, chronic and disabling pain among young employees: a double suffering. Scand J Public Health. 2021 Dec 29;14034948211062314. doi: 10.1177/14034948211062314. Epub 2021 Dec 29. PMID: 34965800.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 77 entries